INTERNATIONAL PATENT: UNIVERSALVAX BIOTECHNOLOGIES (TAIZHOU) CO., LTD., 普大生物科技（泰州）有限公司 FILES APPLICATION FOR "PNEUMOCOCCAL POLYSACCHARIDE-RSV RECOMBINANT PROTEIN CONJUGATE VACCINE AND PREPARATION METHOD THEREFOR"

Posted On: 2025-08-03

GENEVA, Aug. 3 -- UNIVERSALVAX BIOTECHNOLOGIES (TAIZHOU) CO., LTD. (A407-1, Vaccine Engineering Center, No.28 Xinglin Road, Pharmaceutical High Tech Industrial Development ZoneTaizhou, Jiangsu 225300), 普大生物科技（泰州）有限公司 (中国江苏省泰州市医药高新技术产业开发区杏林路28号疫苗工程中心A407-1) filed a patent application (PCT/CN2024/131554) for "PNEUMOCOCCAL POLYSACCHARIDE-RSV RECOMBINANT PROTEIN CONJUGATE VACCINE AND PREPARATION METHOD THEREFOR" on Nov 12, 2024. With publication no....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: UNIVERSALVAX BIOTECHNOLOGIES (TAIZHOU) CO., LTD., 普大生物科技（泰州）有限公司 FILES APPLICATION FOR "PNEUMOCOCCAL POLYSACCHARIDE-RSV RECOMBINANT PROTEIN CONJUGATE VACCINE AND PREPARATION METHOD THEREFOR"